SCHEMBL7358540

SCHEMBL7358540

N=C1OCc2ccccc21

nearest known ligand 0.58

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAOA P21397 2/20 0.58
MAOB P27338 1/20 0.58
ALDH1A1 P00352 7/20 0.41
MAPT P10636 4/20 0.41
RAB9A P51151 2/20 0.41
KMT2A Q03164 3/20 0.40
KDM4E B2RXH2 4/20 0.39
HPGD P15428 3/20 0.39
CYP1A2 P05177 2/20 0.39
HSD17B10 Q99714 2/20 0.39
TYMS P04818 1/20 0.39
CYP2C19 P33261 1/20 0.39
SMN1; SMN2 Q16637 2/20 0.38
GAA P10253 2/20 0.38
NPC1 O15118 1/20 0.38
ALOX12 P18054 1/20 0.38
TDP1 Q9NUW8 1/20 0.38
HRH1 P35367 3/20 0.37
KCNH2 Q12809 2/20 0.37
HTR2B P41595 2/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL31300321 1.00 MAOA (0.58) MAOAMAOBALDH1A1MAPTRAB9A
Hydrochloric Acid SCHEMBL584694 0.98 MAOA (0.56) MAOAMAOBALDH1A1MAPTRAB9A
SCHEMBL28461975 0.78 MAOA (0.46) MAOAMAOBALDH1A1MAPTRAB9A
SCHEMBL13252695 0.76 MAOA (0.69) MAOAMAOBALDH1A1MAPTRAB9A
SCHEMBL6903786 0.73 MAOA (1.00) MAOAMAOBALDH1A1MAPTRAB9A
SCHEMBL22284 0.73 MAOA (1.00) MAOAMAOBALDH1A1MAPTRAB9A
SCHEMBL29395306 0.73 MAOB (0.60) MAOAMAOBALDH1A1MAPTRAB9A
SCHEMBL132696 0.73 MAOB (0.60) MAOAMAOBALDH1A1MAPTRAB9A
SCHEMBL11522370 0.73 MAOA (1.00) MAOAMAOBALDH1A1MAPTRAB9A
SCHEMBL6353583 0.73 MAOA (1.00) MAOAMAOBALDH1A1MAPTRAB9A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 16 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-1436780-A Prepn process of 2,3,3',4'-diphenyl tetraformic dianhydride and its derivative CHANGCHUN APPLIED CHEMISTRY (CN) 2003-08-20 CN claimed
WO-1989002741-A2 INHIBITORS OF HIV-REVERSE TRANSCRIPTASE TO TREAT AIDS THE UPJOHN COMPANY (US) 1989-04-06 WO claimed
CN-114835872-A High-flame-retardance low-heat-conductivity polyurethane foam material and preparation method thereof 格力电器(武汉)有限公司 2022-08-02 CN disclosed
CN-108395363-B Preparation method of 2, 2-bis (3, 4-xylyl) hexafluoropropane 上海如鲲新材料有限公司 2020-10-09 CN disclosed
US-20150045564-A1 Cu-MEDIATED ANNULATION FOR THE EFFECTIVE SYNTHESIS OF 3-SUBSTITUTED PHTHALIDES COUNCIL OF SCIENTIFIC & INDUSTRIAL RESEARCH (IN) 2015-02-12 US disclosed
CN-104341256-A Low-cost and environment-friendly synthesis method of biphenyl derivatives HARBIN INST TECH WEIHAI 2015-02-11 CN disclosed
CN-104262234-A Preparation method of biphenyl derivatives HARBIN INST TECH WEIHAI 2015-01-07 CN disclosed
WO-2013102935-A2 Cu-MEDIATED ANNULATION FOR THE EFFECTIVE SYNTHESIS OF 3-SUBSTITUTED PHTHALIDES COUNCIL OF SCIENTIFIC & INDUSTRIAL RESEARCH (IN) 2013-07-11 WO disclosed
CN-102503884-A Synthesis method of phenylphthalimide analog DANYANG CHEN 2012-06-20 CN disclosed
US-20120077989-A1 CYCLIC IMIDATE LIGANDS UNIVERSITEIT GENT (BE) 2012-03-29 US disclosed
US-20120077989-A1 CYCLIC IMIDATE LIGANDS UNIVERSITEIT GENT (BE) 2012-03-29 US disclosed
WO-2010115903-A1 CYCLIC IMIDATE LIGANDS UNIVERSITEIT GENT (BE) 2010-10-14 WO disclosed
CN-101213286-A Encapsulated phthalocyanine particles CIBA SC HOLDING AG (CH) 2008-07-02 CN disclosed
CN-1215068-C Prepn process of 2,3,3',4'-diphenyl tetraformic dianhydride and its derivative CHANGCHUN APPLIED CHEMISTRY (CN) 2005-08-17 CN disclosed
CN-1436780-A Prepn process of 2,3,3',4'-diphenyl tetraformic dianhydride and its derivative CHANGCHUN APPLIED CHEMISTRY (CN) 2003-08-20 CN disclosed
WO-1989002741-A2 INHIBITORS OF HIV-REVERSE TRANSCRIPTASE TO TREAT AIDS THE UPJOHN COMPANY (US) 1989-04-06 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20150045564-A1 Cu-MEDIATED ANNULATION FOR THE EFFECTIVE SYNTHESIS OF 3-SUBSTITUTED PHTHALIDES SOD1, AOC2, SOD3 MAOA 230/4885MAOB 442/4885ALDH1A1 97/4885
US-20120077989-A1 CYCLIC IMIDATE LIGANDS IDH2, CYCS, NAPRT MAOA 812/4885MAOB 709/4885ALDH1A1 4283/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.